Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Solid Malignancies × ZD4054 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 1 Advanced Solid Malignancies 1

Interventions

Injections 2 vistusertib 1 urelumab 1 sapanisertib 1 durvalumab 1 danvatirsen 1 ceralasertib 1 cediranib 1 atezolizumab 1 ZD4054 1 Topotecan 1 Tiragolumab 1 Rosuvastatin Calcium 1 Radiotherapy 1 Rabeprazole 1 Metformin 1 Irinotecan 1 HM781-36B 1 Furosemide 1 Digoxin 1 ATP Binding Cassette Transporter, Subfamily B, Member 1 1 3-(1-benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00997945 2011-05-19

10mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid Malignancies

AstraZeneca

Phase 1 Completed

Advanced Solid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡